Development of chronic colitis is dependent on the cytokine MIF

Nature Immunology

Volumn 2, Issue 11, 2001, Pages 1061-1066

  De Jong, Ype P ^a   Abadia Molina, Ana C ^a   Satoskar, Abhay R ^b   Clarke, Kareem ^a   Rietdijk, Svend T ^a   Faubion, William A ^a   Mizoguchi, Emiko ^c   Metz, Christine N ^d   Sahli, Mazen Al ^a   Ten Hove, Tessa ^e   Keates, Andrew C ^a   Lubetsky, Jodi B ^f   Farrell, Richard J ^a   Michetti, Pierre ^a   Van Deventer, Sander J ^e   Lolis, Elias ^f   David, John R ^b   Bhan, Atul K ^c   Terhorst, Cox ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d PICOWER INST FOR MEDICAL RESEARCH   (United States)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CYTOKINE; CYTOKINE ANTIBODY; IMMUNOGLOBULIN; INFLIXIMAB; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MERCAPTOPURINE; METHOTREXATE; PREDNISONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CELL TYPE; CLINICAL ARTICLE; COLITIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG TARGETING; FEMALE; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INTESTINE FLORA; MALE; MOUSE; MUCOSA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; COLITIS; CROHN DISEASE; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; NUCLEAR PROTEINS; RADIATION CHIMERA; WEIGHT LOSS;

EID: 17944369782     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni720     Document Type: Article

References (32)

1. Role of macrophage migration inhibitory factor in the regulation of the immune response
2. Macrophage migration inhibitory factor: A regulator of glucocoritcoid activity with a critical role in inflammatory disease
3. MIF as a glucocorticoid-induced modulator of cytokine production
4. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor
5. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis
6. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
7. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome
8. Pathways of T cell pathology in models of chronic intestinal inflammation
9. Role of cytokines in the pathogenesis of inflammatory bowel disease
10. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease
11. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of expression by T cells
12. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice
13. + T cells
14. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis
15. hi T cells
16. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
17. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion
18. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration
19. + T cells by blocking the CD40-CD154 interactions
20. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: Amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein
21. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type I response and ability to transfer disease
22. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in tgε26 mice
23. + T cells are important for the balance between protective and pathogenic cell- mediated immunity
24. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice
25. The Crohn's Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: A review of instruments to assess Crohn's disease
26. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group
27. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity
28. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction
29. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria
30. Antibodies to interleukin 12 abrogate established experimental colitis in mice
31. Protection from septic shock by neutralization of macrophage migration inhibitory factor
32. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity